Paremyd
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
BACKGROUND
Paremyd, a mydriatic formulation of 0.25% tropicamide and 1.0% hydroxyamphetamine hydrobromide provides adequate…
BACKGROUND
Paremyd, consisting of a combination of 1.0 percent hydroxyamphetamine and 0.25 percent tropicamide, is a commercially…
BACKGROUND
This study was designed to evaluate the effect of Paremyd, a combination of 1.0 percent hydroxyamphetamine…
Background: The demand for a milder, yet effective dilation drop prompted Allergan to introduce ParemydTM to the eye care…
We conducted a study to evaluate the ability of dapiprazole 0.5% ophthalmic solution to reverse accommodative loss brought about…